From the Department of General Anesthesia, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.
Anesthesiology. 2016 Mar;124(3):624-40. doi: 10.1097/ALN.0000000000000981.
Although neonatal exposure to anesthetic drugs is associated with memory deficiency in rodent models and possibly in pediatric patients, the underlying mechanisms remain elusive. The authors tested their hypothesis that exposure of the developing brain to anesthesia triggers epigenetic modification, involving the enhanced interaction among transcription factors (histone deacetylase 2, methyl-cytosine-phosphate-guanine-binding protein 2, and DNA methyltransferase 1) in Bdnf promoter region(s) that inhibit brain-derived neurotrophic factor (BDNF) expression, resulting in insufficient drive for local translation of synaptic mRNAs. The authors further hypothesized that noninvasive environmental enrichment (EE) will attenuate anesthesia-induced epigenetic inhibition of BDNF signaling and memory loss in rodent models.
Seven days after birth (P7), neonatal rats were randomly assigned to receive either isoflurane anesthesia for 6 h or sham anesthesia. On P21, pups were weaned, and animals were randomly assigned to EE or a standard cage environment (no EE). Behavioral, molecular, and electrophysiological studies were performed on rats on P65.
The authors found a substantial reduction of hippocampal BDNF (n = 6 to 7) resulting from the transcriptional factors-mediated epigenetic modification in the promoter region of Bdnf exon IV in rats exposed postnatally to anesthetic drugs. This BDNF reduction led to the insufficient drive for the synthesis of synaptic proteins (n = 6 to 8), thus contributing to the hippocampal synaptic (n = 8 to 11) and cognitive dysfunction (n = 10) induced by neonatal anesthesia. These effects were mitigated by the exposure to an enriched environment.
The findings of this study elucidated the epigenetic mechanism underlying memory deficiency induced by neonatal anesthesia and propose EE as a potential therapeutic approach.
尽管在啮齿动物模型和可能的儿科患者中,新生儿暴露于麻醉药物与记忆缺陷有关,但潜在机制仍不清楚。作者检验了他们的假设,即发育中的大脑暴露于麻醉会触发表观遗传修饰,涉及转录因子(组蛋白去乙酰化酶 2、甲基胞嘧啶磷酸鸟嘌呤结合蛋白 2 和 DNA 甲基转移酶 1)之间增强的相互作用,从而抑制脑源性神经营养因子(BDNF)的表达,导致局部翻译突触 mRNA 的驱动力不足。作者进一步假设,非侵入性环境富集(EE)将减轻麻醉诱导的 BDNF 信号转导的表观遗传抑制和啮齿动物模型中的记忆丧失。
出生后 7 天(P7),新生大鼠随机分为接受异氟烷麻醉 6 小时或假麻醉。在 P21,幼鼠断奶,动物随机分为 EE 或标准笼环境(无 EE)。在 P65 对大鼠进行行为、分子和电生理研究。
作者发现,在新生期暴露于麻醉药物的大鼠中,BDNF(n = 6 至 7)在转录因子介导的 Bdnf 外显子 IV 启动子区域的表观遗传修饰下,大量减少。这种 BDNF 的减少导致突触蛋白的合成驱动力不足(n = 6 至 8),从而导致海马突触(n = 8 至 11)和认知功能障碍(n = 10)由新生儿麻醉引起。这些影响通过暴露于丰富的环境得到缓解。
本研究的结果阐明了新生儿麻醉诱导记忆缺陷的表观遗传机制,并提出 EE 作为一种潜在的治疗方法。